India's Orchid Pharma rises on Q2 profit jump

Poly Medicure

12/11/2024 06:57

** Shares of active pharmaceutical ingredients maker Orchid
Pharma  ORCD.NS  rise 4.8% to 1,522.35 rupees
** Co posts a 37.5% rise in Sept-qtr consolidated profit at
272.4 million rupees ($3.2 mln); income from ops rose 12%
    ** Avg rating of three analysts covering ORCD at "strong
buy" vs "hold" for peers Natco Pharma  NATP.NS  and Poly
Medicure  PLMD.NS 
    ** ORCD's median PT is at 1,710 rupees - LSEG data
    ** Stock up ~114% so far this year vs a 76% and 85% rise in
NATP and PLMD
     
    ($1 = 84.3930 Indian rupees)

(Reporting by Dimpal Gulwani in Bengaluru)
((dimpal.gulwani@thomsonreuters.com))